Decahedron Ltd. is a pharmaceutical wholesaler incorporated in the UK in August 2011. It is audited by the MHRA under European GDP (Good Distribution Practices). They are also a full member of the EAEPC and have been audited by TÜV on their behalf. They import and export branded, generic and unlicensed POM, OTCs, and medical devices all over the world. They also participate in governmental tenders and register dossiers in new territories.
On October 18, 2016, Cosmos Holdings Inc. entered into a Memorandum of Understanding with Decahedron LTD and Decahedron’s sole shareholder Nikolaos Lazarou. The MOU provides that Cosmos Holdings intends to acquire all of the issued and outstanding shares of Decahedron from Nikolaos Lazarou. In exchange for the shares of Decahedron, the Company will issue to Nikolaos Lazarou shares of Cosmos Holding’s common stock. Following the closing of the transaction, Nikolaos Lazarou shall also be retained as a Director and COO of Decahedron.